- Home
- NKTR vs BL Comparison
NKTR vs BL Comparison
Compare NKTR & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | BL |
|---|---|---|
| Founded | 1990 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NKTR | BL |
|---|---|---|
| Price | $81.33 | $31.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 14 |
| Target Price | ★ $130.00 | $55.64 |
| AVG Volume (30 Days) | 722.9K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $307,711,000.00 | $177,031,000.00 |
| Revenue This Year | N/A | $12.62 |
| Revenue Next Year | N/A | $10.90 |
| P/E Ratio | ★ N/A | $80.37 |
| Revenue Growth | ★ 86.00 | 43.78 |
| 52 Week Low | $0.57 | $29.67 |
| 52 Week High | $81.25 | $59.57 |
Technical Indicators
Market Signals| Indicator | NKTR | BL |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 30.41 |
| Support Level | $64.30 | N/A |
| Resistance Level | N/A | $58.77 |
| Average True Range (ATR) | 4.75 | 1.80 |
| MACD | 0.37 | -0.53 |
| Stochastic Oscillator | 99.77 | 12.38 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.